Nautilus Biotechnolgy's total assets for Q1 2026 were $177.78M, a decrease of -6.98% from the previous quarter. NAUT total liabilities were $33.36M for the fiscal quarter, a -2.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.